This invention is directed to the discovery that 11-Beta Hydroxysteroid Dehydrogenase Type 1 may be a common molecular etiology for visceral obesity and the metabolic syndrome of obesity as well a treatment for diabetes, especially type II diabetes. The present invention also relates to the use of certain compounds as inhibitors of 17-Beta Hydroxysteroid Dehydrogenase Type 1 and their use for the treatment of cancer, especially breast cancer.

 
Web www.patentalert.com

< Agonist and antagonist ligands of the nociceptin receptor

< Tetrahydro-indazole cannabinoid modulators

> Substituted fused heterocyclic C-glycosides

> Preparation of trans-fused 3,3a,8,12b-tetrahydro-2H-dibenzo[3,4:6,7]cycloh- epta[1,2-b]furan derivatives

~ 00214